RNA Q1 2021 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+99.1% YoY

Gross Profit

-$18M-664.7% margin

Operating Income

-$24M-882.3% margin

Net Income

-$24M-881.8% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

+26.2%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$315M

Total Liabilities

$29M

Stockholders' Equity

$286M

Cash & Equivalents

$301M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$1M	+99.1%
Gross Profit	-$18M	$1M	-1423.5%
Operating Income	-$24M	-$6M	-287.9%
Net Income	-$24M	-$6M	-291.8%